文献速递神经肿瘤

68Ga-DOTATATE PET/CT的SUV-max与脑膜瘤WHO分级及RNA风险分类相关

SUV-max of 68Ga-DOTATATE PET/CT correlates with WHO grade and RNA risk classification in meningioma.
PubMed 文献 · J Neurooncol · 2025-10-23

高WHO级别、SSTR2a阳性及男性患者的SUV-max中位值显著更高,SUV-max>15.55独立关联高WHO级别,结合性别和手术史的列线图有助于术前识别高分级风险。

要点

  • SUV-max在高WHO级别、SSTR2a阳性及男性脑膜瘤患者中显著升高。
  • SUV-max>15.55独立关联高WHO级别,可辅助术前风险分层。
  • 整合SUV-max、性别和手术史的列线图在术前识别高分级风险中表现良好。

核心结论

  • 68Ga-DOTATATE PET/CT的SUV-max在高分级和高RNA风险评分组脑膜瘤中显著更高。
  • SUV-max>15.55独立关联高WHO级别。

研究设计与样本

  • 测量68Ga-DOTATATE PET/CT的半定量指标SUV-max、SUV-median、SUV-mean和MTV,分析其与临床病理特征的相关性。

主要发现

  • 高WHO级别脑膜瘤的SUV-max中位值显著更高(P=0.017)。
  • SSTR2a阳性表达者SUV-max中位值显著更高(P=0.023),男性患者亦显著更高(P=0.002)。
  • SSTR2 RNA表达在SSTR2a阳性组显著升高,并与SUV-max、SUV-median、SUV-mean正相关。
  • 高RNA评分风险组的SUV-max显著高于中、低风险组。
  • SUV-max>15.55独立关联高WHO级别(P=0.014)。

关键数值与推荐

  • SUV-max>15.55为独立关联高WHO级别的阈值(P=0.014)。
  • 列线图整合SUV-max、性别和手术史用于术前识别高WHO级别风险患者。

临床怎么用

  • 可利用68Ga-DOTATATE PET/CT的SUV-max辅助术前评估脑膜瘤WHO分级风险。
  • 结合SUV-max、性别和手术史的列线图可支持术后放疗等临床决策。

局限性

  • 单中心回顾性研究,样本量有限,WHO 3级仅2例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 68Ga-DOTATATE binds to somatostatin receptors (SSTR) and is used for PET/CT imaging for diagnosing meningioma and guiding postoperative radiotherapy. However, the relationship between the clinicopathological characteristics and the imaging features of 68Ga-DOTATATE PET/CT in meningioma remains undetermined. METHODS: We conducted a retrospective study at a single neurosurgical center. Semiquantitative indices of 68Ga-DOTATATE PET/CT, including maximum standardized uptake value (SUV-max), median standardized uptake value (SUV-median), mean standardized uptake value (SUV-mean), and metabolic tumor volume (MTV), were measured. The correlations between these parameters and clinicopathological characteristics were analyzed. RESULTS: Eighty patients were retrospectively analyzed, including 45 with WHO grade 1 meningiomas, 33 with grade 2, and 2 with grade 3. The median SUV-max value was significantly higher in meningiomas with high WHO grade (P = 0.017), positive SSTR2a expression (P = 0.023), and in male patients (P = 0.002). Bulk RNA data was available in forty patients. RNA expression of SSTR2 was significantly elevated in the SSTR2a-positive group and correlated positively with SUV-max, SUV-median, and SUV-mean. Furthermore, the high RNA scores risk group exhibited significantly higher SUV-max compared to the intermediate- and low-risk groups. Of note, an SUV-max > 15.55 (P = 0.014) was independently associated with high WHO grade. Lastly, a nomogram incorporating SUV-max, gender, and surgical history demonstrated robust performance in preoperatively identifying patients at risk for high WHO grade, offering the potential utility of 68Ga-DOTATATE PET/CT in clinical practice. CONCLUSION: SUV-max of 68Ga-DOTATATE PET/CT was significantly higher in high grade and high RNA score risk groups of meningioma. Of note, an SUV-max > 15.55 was independently associated with high WHO grade.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ren L, Deng J, Xu J, et al. SUV-max of 68Ga-DOTATATE PET/CT correlates with WHO grade and RNA risk classification in meningioma. J Neurooncol. 2025. PMID: 41129031. doi:10.1007/s11060-025-05307-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。